Table 4 Clinical characteristics at baseline (initial evaluation) and at re-evaluation 3 years later
Baseline (initial evaluation) | 3 years later (re-evaluation) | p value | |
|---|---|---|---|
(a) SS group (n = 23) | |||
OHIP-14 score (out of 56) | 10.2 ± 8.8 (n = 22) | 12.6 ± 9.2 (n = 22) | 0.040 |
Salivary flow rate (mL/10 min) | 8.1 ± 5.3 | 7.4 ± 5.1 | 0.149 |
Salivary EGF output (pg/10 min) | 10,158.4 ± 9820.9 | 8352.8 ± 7813.3 | 0.032 |
(b) Non-SS group (n = 14) | |||
OHIP-14 score (out of 56) | 9.1 ± 6.8 | 10.7 ± 9.4 | 0.169 |
Salivary flow rate (mL/10 min) | 16.8 ± 6.7 | 16.7 ± 6.0 | 0.628 |
Salivary EGF output (pg/10 min) | 13,623.1 ± 9546.2 | 11,904.9 ± 6995.4 | 0.184 |